Our main contribution to the global sustainable development agenda is closely aligned with our mission – to transform the lives of people with rare diseases. Sobi’s strategy comprises four business priorities and two sustainability priorities, both of which are integral to our success.
Maintain commitment to patients
- Access to treatment
- Patient centricity & engagement
- Patient & product safety
- Responsible marketing & sales
- Ethical R&D
Always act responsibly
- Safe, healthy & fair working conditions
- An inclusive & diverse workplace
- Reduction of environmental & climate impact
- Reducing resource consumption
- Responsible sourcing
- Compliance & corruption prevention
The priorities are built on 21 material sustainability matters linked to climate change, pollution, water, circularity, own workers, workers in the value chain, consumers and end-users, and business ethics.
We contribute to the 2030 Agenda, the UN Sustainable Development Goals, and the Paris Agreement. These are the seven SDGs we have identified as most relevant to our work and where we believe we can make the greatest impact.
UN Global Compact
Sobi is a signatory to the UN Global Compact and has integrated the Ten Principles of the Global Compact into all our business operations. We commit to operating in a way that contributes to achieving the UN SDGs and the Paris Agreement.
Access in the developing world
Sobi has supported the World Federation of Hemophilia Humanitarian Aid Program since 2014.
Responsible Sourcing Programme
We are committed to working only with partners who embrace the same level of standards as ours.